Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Shares Outstanding (2012 - 2026)

Precigen (PGEN) posted quarterly Shares Outstanding (Entity) of $355.9 million for Q1 2026, up 20.59% year-over-year from $295.1 million in Q1 2025, and up 0.56% quarter-over-quarter from $353.9 million in Q4 2025.

Analysis

Precigen (PGEN) Shares Outstanding (2012 - 2026) Analysis & Trends

Precigen (PGEN) has reported Shares Outstanding (Entity) for 15 consecutive years, with $355.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 20.59% year-over-year to $355.9 million; the TTM figure through Mar 2026 stood at $355.9 million (up 20.59% YoY), while the FY2025 annual figure was $353.9 million, up 20.84% from the prior year.
  • Shares Outstanding (Entity) improved to $355.9 million in Q1 2026 per PGEN's latest filing, from $353.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $355.9 million in Q1 2026 and bottomed at $207.7 million in Q1 2022.
  • Historically, Shares Outstanding (Entity) has averaged $271.2 million across 5 years, with a median of $256.4 million in 2023.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) rose 23.18% — and 2024, when it advanced 0.36%.
  • Precigen's Shares Outstanding (Entity) stood at $208.2 million in 2022, then rose by 23.18% to $256.4 million in 2023, then grew by 14.22% to $292.9 million in 2024, then rose by 20.84% to $353.9 million in 2025, then gained by 0.56% to $355.9 million in 2026.
  • Business Quant data shows PGEN's Shares Outstanding (Entity) at $355.9 million in Q1 2026, $353.9 million in Q4 2025, and $353.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 210.89 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 445.06 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 217.35 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn 356.89 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 356.89 Mn
Mar 31, 2026 354.29 Mn
Dec 31, 2025 312.98 Mn
Sep 30, 2025 307.17 Mn
Jun 30, 2025 296.43 Mn
Mar 31, 2025 293.88 Mn
Dec 31, 2024 267.73 Mn
Sep 30, 2024 275.88 Mn
Jun 30, 2024 252.37 Mn
Mar 31, 2024 249.22 Mn
Dec 31, 2023 244.54 Mn
Sep 30, 2023 248.52 Mn
Jun 30, 2023 248.00 Mn
Mar 31, 2023 229.77 Mn
Dec 31, 2022 200.36 Mn
Sep 30, 2022 200.67 Mn
Jun 30, 2022 200.46 Mn
Mar 31, 2022 199.63 Mn
Dec 31, 2021 197.76 Mn
Sep 30, 2021 199.18 Mn